logo
logo
AI Products 

United States of America Viscosupplementation Market will grow at highest pace owing to rising geriatric population

avatar
Kajal Patil
United States of America Viscosupplementation Market will grow at highest pace owing to rising geriatric population

Viscosupplementation involves injecting hyaluronic acid into the knee joint to supplement the viscosity of the synovial fluid, thereby reducing pain and improving joint mobility. Hyaluronic acid acts as a lubricant and shock absorber for joints. It plays a critical role in protecting cartilage and bones from damage. The viscosupplementation procedure is minimally invasive and helps relieve osteoarthritis pain without surgery. The United States viscosupplementation market has been gaining significant demand due to the growing prevalence of osteoarthritis among the geriatric population. According to estimates, over 30 million people in the US suffer from osteoarthritis. By 2040, an estimated 78 million US adults are projected to have doctor-diagnosed arthritis.

The United States of America Viscosupplementation Market is estimated to be valued at USD 1.54 Bn in 2024 and is expected to reach USD 2.87 Bn by 2031, growing at a compound annual growth rate (CAGR) of 8.1% from 2024 to 2031.

Key players operating in the United States of America viscosupplementation market are Johnson & Johnson.,F. Hoffmann-La Roche AG,Zimmer Biomet,Sanofi S.A.,Anika Therapeutics Inc. Johnson & Johnson holds the highest market share due to its HA knee injection product named Durolane.

The growing geriatric population and rising prevalence of osteoarthritis are driving the demand for United States of America Viscosupplementation Market. According to estimates, around 54 million adults aged 18 years and older will have doctor-diagnosed arthritis by 2030. The number of osteoarthritis-related ambulatory care visits in the US is projected to increase by 49% between 2018 and 2040.Technological advancements are further expanding the application of viscosupplementation. New cross-linked hyaluronic acid formulations with extended residence time in the joint are being developed. They help improve treatment outcomes by providing symptomatic relief for six months or more with a single injection. Viscosupplementation augmented with biologic adjuncts is also being investigated.

Market TrendsIncreasing preference for minimally invasive treatments- The preference for minimally invasive medical procedures over surgeries is growing among healthcare providers and patients. Viscosupplementation provides an effective alternative to total knee replacement for managing osteoarthritis symptoms in the short to medium-term without surgery.Growing popularity of single-injection viscosupplements- New cross-linked formulations that require just one injection and provide relief for 6 months or longer are gaining popularity. This enhances patient compliance and lowers treatment costs compared to multi-dose regiments.

Market OpportunitiesUntapped markets - Viscosupplementation penetration in the US remains moderate and significant opportunities exist in less-developed regions. Increasing reimbursement coverage and awareness can help expand access.

Combination therapies - The potential of HA combination therapies with other disease-modifying drugs, biologic agents, and platelet rich plasma offers avenues for customized osteoarthritis treatment approaches.

Impact of COVID-19 on United States of America Viscosupplementation Market growth:The COVID-19 pandemic has negatively impacted the growth of United States of America viscosupplementation market. During the initial months of pandemic, all non-emergency procedures were postponed to focus medical resources on COVID-19 patients. This led to sharp decline in viscosupplementation procedures being performed. However, as restrictions were eased, the market is gradually recovering. The demand is increasing as patients are getting viscosupplementation treatments to manage their joint pain. But concerns still remain around virus spread in hospitals and clinics. Manufacturers are focusing on developing single-dose vials and kits to minimize risk of contamination and enable social distancing. Telehealth and digital solutions are also being utilized more for follow up consultations. It is estimated that the market may take 12-18 months post pandemic to reach pre-COVID sales levels depending on broader economic recovery. Ongoing vaccine rollout and adaptation of new safety protocols provide hope for market growth going ahead.

Geographical concentration of United States of America Viscosupplementation Market:In terms of value, the United States of America viscosupplementation market is highly concentrated in regions like California, Texas, New York and Florida. This is because these states have high population densities and number of orthopedic specialists performing knee osteoarthritis treatments. California viscosupplementation market alone contributes over 20% of the national revenue led by demand centers in Los Angeles and San Francisco bay areas. Availability of advanced healthcare infrastructure, medical reimbursements, awareness among population about treatment options and aging demography are major factors for market concentration in these regions.

Fastest growing region in United States of America Viscosupplementation Market:The Southeast region comprising of states like Georgia, North Carolina, Tennessee is expected to be the fastest growing market for viscosupplementation in the United States. This is largely attributed to increasing morbidity rates of knee osteoarthritis due to growing obese population in this region. States like Georgia and North Carolina are witnessing rapid economic development and expansion of private insurance coverage leading to uptick in elective procedures. Coupled with large presence of medical device companies, rising medical tourism and initiative to develop ambulatory surgical centers, the viscosupplementation adoption is surging in this region at over 10% annually.

Get more insights on - United States of America Viscosupplementation Market

Get this Report in Japanese Language: アメリカ合衆国の粘度サプリメント市場

Get this Report in Korean Language: 미국 점성 보충 시장

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)


collect
0
avatar
Kajal Patil
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more